BeStock  
Markets › Compare › AMLX vs LQDA

AMLX vs LQDA

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
AMLX · Amylyx Pharmaceuticals$26.02 ▼ 0.69%
LQDA · Liquidia$54.43 ▼ 3.88%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

63127191255318Nov 24, '25May 26, '26Nov 20, '26
  • AMLX +75.6%
  • LQDA +82.2%

Head to head

MetricAMLXLQDA
Price$26.02$54.43
Change today▼ 0.69%▼ 3.88%
Market cap$3.35B$4.90B
Return, 3 months-31.8%-22.5%
Return, year to date+115.4%+57.8%
Return, 1 year+77.4%+87.0%
P/E (TTM)––
P/B4.4-193.0
P/E percentile vs own 5y3rd0th
Dividend yield––
Revenue growth (YoY, latest qtr)–+314.6%
Net profit growth (YoY)-32.3%-6,589.2%
Gross margin–92.7%
Operating margin–47.1%
Net margin–-15.1%
Return on equity-30.1%–
Analyst target vs. price+77.7%+16.2%
Analyst buy share100%75%
RSI (14)3959
30-day volatility58.0%94.0%
Max drawdown, 1 year-34.4%-71.5%
Trend readLeaning bearishLeaning bullish
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • LQDA is the largest of the group by market value.
  • LQDA has returned the most over the past year.
  • AMLX has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top